{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:14:10Z","timestamp":1790990050765,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T00:00:00Z","timestamp":1093305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Microbiology and Immunology"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p>This study assessed the extent of \u03b2\u2010lactamase\u2010producing bacteria in subgingival plaque samples obtained from 25 patients with refractory marginal periodontitis in the USA. \u03b2\u2010Lactamase\u2010positive isolates were characterized using commercial diagnostic kits and partial sequencing of the 16S rRNA gene. The susceptibilities to different antimicrobial agents were tested and, in addition, the isolates were screened for the presence of extended spectrum \u03b2\u2010lactamases (ESBLs). \u03b2\u2010lactamase\u2010producing bacteria were detected in 18 (72%) patients. The most prominent \u03b2\u2010lactamase\u2010producing organisms belonged to the anaerobic genus <jats:italic>Prevotella<\/jats:italic>. Other enzyme\u2010producing anaerobic strains were <jats:italic>Fusobacterium nucleatum, Propionibacterium acnes<\/jats:italic> and <jats:italic>Peptostreptococcus<\/jats:italic> sp. Facultative bacteria, such as <jats:italic>Burkholderia<\/jats:italic> spp., <jats:italic>Ralstonia pickettii<\/jats:italic>, <jats:italic>Capnocytophaga<\/jats:italic> spp., <jats:italic>Bacillus<\/jats:italic> spp., <jats:italic>Staphylococcus<\/jats:italic> spp. and <jats:italic>Neisseria<\/jats:italic> sp., were also detected among the enzyme\u2010producers. Minimum inhibitory concentrations (MICs) of ampicillin and amoxicillin were in the range 1.5\u2013256\u2003\u03bcg\/ml and 4\u2013256\u2003\u03bcg\/ml, respectively, for the isolates of the <jats:italic>Prevotella<\/jats:italic> species. All <jats:italic>Prevotella<\/jats:italic> isolates were susceptible to amoxicillin\/clavulanate and metronidazole, but they showed variable resistance to tetracyclines. Two of the <jats:italic>Prevotella<\/jats:italic> isolates had high MICs of cefotaxime and ceftazidime. ESBL activity was not detected in any of the \u03b2\u2010lactamase\u2010producing isolates by the Etest method. Thus, our study demonstrated a wide variety of \u03b2\u2010lactamase\u2010producing bacteria that may play a role in refractory periodontal disease.<\/jats:p>","DOI":"10.1111\/j.1399-302x.2004.00159.x","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T15:16:19Z","timestamp":1093360579000},"page":"303-308","source":"Crossref","is-referenced-by-count":62,"title":["\u03b2\u2010Lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis"],"prefix":"10.1111","volume":"19","author":[{"given":"T.","family":"Handal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. B.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,8,24]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.41.2.484","article-title":"Comparative in vitro activities of trovofloxacin (CP 99, 219) and other antimicrobials against clinically significant anaerobes","volume":"41","author":"Aldridge KE","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_11_3_2","first-page":"296","article-title":"A modified formula for the preparation of Stuart's transport medium","volume":"58","author":"Amies CR","year":"1967","journal-title":"Can J Public Health"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1998.tb00748.x"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1980.51.9.530"},{"key":"e_1_2_11_6_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajhp\/52.6_Suppl_2.S3","article-title":"Bacterial resistance to \u03b2\u2010lactam antibiotics","volume":"52","author":"Danziger LH","year":"1995","journal-title":"Am J Health-Syst Pharm"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00352-7"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0902-0055.2001.00096.x"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302X.1999.140604.x"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.8.1501"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.4.797"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.2.193"},{"key":"e_1_2_11_13_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/jb.172.1.495-497.1990","article-title":"Detection of conjugal transfer systems in oral, black\u2010pigmented Bacteroides spp","volume":"23","author":"Guiney DG","year":"1990","journal-title":"J Bacteriol"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.4.1443-1446.2003"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.Supplement_1.S44"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051x.2000.027007520.x"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.23.6.1127-1133.1986"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0266-4356(90)90085-Y"},{"key":"e_1_2_11_19_2","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/AAC.43.10.2383","article-title":"\u03b2\u2010Lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents","volume":"43","author":"M\u00e4tt\u00f6 J","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_11_20_2","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria.","author":"National Committee for Clinical Laboratory Standards (NCCLS).","year":"1997"},{"key":"e_1_2_11_21_2","first-page":"1270","article-title":"Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood","volume":"43","author":"Nyfors S","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_11_22_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1128\/AAC.43.7.1591","article-title":"\u03b2\u2010Lactamase production by oral gram\u2010negative species in infants in relation to previous antimicrobial therapy","volume":"43","author":"Nyfors S","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1995.tb00166.x"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1994.tb00067.x"},{"key":"e_1_2_11_25_2","first-page":"232","article-title":"Antibiotic prescribing practices among Norwegian dentists","volume":"100","author":"Preus HR","year":"1992","journal-title":"Scand J Dent Res"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.10.2197"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1992.tb01220.x"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.Supplement_2.S350"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.38-4-460"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1097(97)00521-1"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1997.tb00226.x"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/516222"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1993.64.8s.772"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1987.tb00276.x"},{"key":"e_1_2_11_35_2","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/AAC.40.9.2232","article-title":"In vitro activities of trovofloxacin against 557 strains of anaerobic bacteria","volume":"40","author":"Wexler HM","year":"1996","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Oral Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-302x.2004.00159.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-302x.2004.00159.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:16:14Z","timestamp":1697246174000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-302x.2004.00159.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,24]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1399-302x.2004.00159.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-302x.2004.00159.x","archive":["Portico"],"relation":{},"ISSN":["0902-0055","1399-302X"],"issn-type":[{"value":"0902-0055","type":"print"},{"value":"1399-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,24]]}}}